Biosynthesis and phosphorylation of vaccinia virus structural protein VP11.
One of the major DNA binding proteins contained in vaccinia virus is an 11-kDA species denoted VP11. The biosynthesis of VP11, a late polypeptide, occurs subsequent to the initiation of viral DNA replication. In particular, VP11 synthesis is blocked by cytosine arabinoside, a specific inhibitor of DNA synthesis. We show here that VP11 is specifically phosphorylated subsequent to translation. Phosphorylated VP11 is present both in viral core particles and in the cytoplasm of virus-infected cells. Kinetic analysis reveals that the total amount of phosphorylated VP11 species increases rapidly and remains approximately constant for as long as 17 hr postinfection. Phosphorylation occurs at two different serine residues, progressing from either site singly to the diphosphorylated product. Under steady-state conditions, the phosphorylated derivative constitutes approximately 85% of total VP11 in extracts of vaccinia virus-infected cells. Even though 15% of the VP11 remains unphosphorylated in cell extracts, only phosphorylated VP11 is found in mature viral cores.
D003561:Cytarabine / Q000494:pharmacology; D004261:DNA Replication / Q000187:drug effects; D004268:DNA-Binding Proteins / Q000096:biosynthesis*; D007700:Kinetics; D010750:Phosphoproteins / Q000096:biosynthesis; D010766:Phosphorylation; D011499:Protein Processing, Post-Translational; D014616:Vaccinia virus / Q000378:metabolism*; D014764:Viral Proteins / Q000096:biosynthesis*; D015678:Viral Structural Proteins; D014779:Virus Replication / Q000187:drug effects
D004268:DNA-Binding Proteins; D010750:Phosphoproteins; D014764:Viral Proteins; D015678:Viral Structural Proteins; D003561:Cytarabine